Table 3.
Adjusted odds ratios/hazard ratios of TyG index as continuous variable (per unit) for clinical outcomes.
| Age and sex—adjusted | Multivariable—adjusted | |||||
|---|---|---|---|---|---|---|
| n | Events (%) | OR/HR (95%CI) | P | OR/HR (95%CI) | P | |
| Stroke recurrence | 16310 | 1192 (7.31) | 1.23 (1.14-1.33) | <0.0001 | 1.19 (1.09-1.30) | <0.0001 |
| All-cause mortality | 16310 | 1353 (8.30) | 1.13 (1.04-1.22) | 0.003 | 1.12 (1.02-1.22) | 0.01 |
| Poor functional outcomes | 16310 | 3655 (22.41) | 1.06 (1.00-1.12) | 0.045 | 1.00 (0.94-1.06) | 0.93 |
| Neurologic worsening | 15511 | 908 (5.85) | 1.19 (1.08-1.31) | 0.0004 | 1.19 (1.07-1.32) | 0.001 |
TyG index, triglyceride glucose index; Q1–Q4, TyG index quartiles; CI, confidence interval; HR, hazard ratio; OR, odds ratio; HR for stroke recurrence and all-cause mortality, while OR for poor functional outcome, and neurologic worsening; Statistically significant P values are shown in bold; The multivariable-adjusted model included age, sex, body mass index, systolic blood pressure, diastolic blood pressure, previous or current smoker, history of hypertension, history of atrial fibrillation, history of diabetes mellitus, history of previous stroke, pre-hospital medication history of antihypertensive drugs and hypoglycemic drugs.